AtriCure's CEO Discusses Q1 2012 Results - Earnings Call Transcript

ArtiCure, Inc. (ATRC)

Q1 2012 Earnings Conference Call

May 3, 2012 10:00 AM ET


David Drachman - President and Chief Executive Officer

Sarah Luken - Investor Relations Associate and Executive Assistant


Rick Wise - Leerink Swann

Matt Dolan – Roth Capital

Tom Gunderson - Piper Jaffray

Jason Mills – Canaccord Genuity

Charley Jones – Barrington Research

Larry Haimovitch – HMTC



Good afternoon, and welcome to the AtriCure’s First Quarter 2012 Earnings Conference Call. My name is, Karen, and I’ll be your coordinator for the call today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of today’s call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Mr. David Drachman, President and Chief Executive Officer of AtriCure. Mr. Drachman, please proceed.

David J. Drachman

Thank you, Karen. Good morning, and welcome to our first quarter earnings conference call. At this time, I would like to turn the call over to Sarah Luken our Investor Relations Associate and Executive Assistant, for a few introductory comments.

Sarah Luken

Thank you, Dave, and good afternoon, everyone. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call me at 513-304-8931, and I will fax or e-mail you a copy.

Before we begin today, let me remind you that the company’s remarks may include forward-looking statements. These statements include, but are not limited to, those that address activities, events or developments that AtriCure expects, believes or anticipates, will or may occur in the future, such as revenue and earnings estimates, other predictions of financial performance, launches of new products and market acceptance of new products.

If you liked this article you might like

These 5 Stocks Are Poised for Breakouts

AtriCure Suffers From Weak Chart, Downgrade

AtriCure Suffers From Weak Chart, Downgrade

5 Breakout Stocks to Buy Off Weakness

Today's Weak On High Volume Stock: AtriCure (ATRC)

AtriCure (ATRC) Weak On High Volume Today